항암단 투여로 호전된 진행성 또는 전이성 담낭암 연속환자증례
Case Series of Advanced or Metastatic Gallbladder Cancer Patients Treated with Hang-Am-Dan
2
조회
0
다운로드
9
인용
0
참고문헌
키워드
초록
Objective : To investigate the therapeutic effects of Hang-Am-Dan(HAD) on gallbladder cancer patients. Method : We prescribed HAD three times a day(3,000-6,000 mg/day) during a treatment period of 8 and 34 months respectively. Computed tomography(CT) was taken to evaluate the therapeutic efficacy. Results : Two patients diagnosed with gallbladder cancer were recommended to go through chemotherapy. However, they refused the standard regimen due to their old age and the fear of side effects, and chose to go with Oriental medicine treatments instead. The patients were treated for 8 and 34 months respectively. Each patient showed stable disease(SD) state during the treatment period. Conclusion : According to these cases, it could be concluded that HAD may offer potential benefits in treating gallbladder cancer patients.
Abstract
Objective : To investigate the therapeutic effects of Hang-Am-Dan(HAD) on gallbladder cancer patients. Method : We prescribed HAD three times a day(3,000-6,000 mg/day) during a treatment period of 8 and 34 months respectively. Computed tomography(CT) was taken to evaluate the therapeutic efficacy. Results : Two patients diagnosed with gallbladder cancer were recommended to go through chemotherapy. However, they refused the standard regimen due to their old age and the fear of side effects, and chose to go with Oriental medicine treatments instead. The patients were treated for 8 and 34 months respectively. Each patient showed stable disease(SD) state during the treatment period. Conclusion : According to these cases, it could be concluded that HAD may offer potential benefits in treating gallbladder cancer patients.
참고문헌 (20)
- Goetze T, "Does laparoscopy worsen the prognosis for incidental gallbladder cancer?", Surg Endosc., 20(2), pp.286~293 (2006)
- Jemal A, , Cancer statistics, 56(2), pp.106~130 (2006)
- Lim SB, "A clinical study of prognostic factors in gallbladder cancer", J Korean Surg Soc, 55(1), pp.120~131 (1998)
- Grobmyer SR, "Gallbladder cancer in the twentieth century: single institution's experience", World J Surg, 28(1), pp.47~49 (2004)
- 박재갑, "종양학", pp.417~ (2003), (주)일조각
- Fauci, "해리슨 내과학 17판", pp.708~ (2010), 도서출판 MIP
- 서영광, "폐전이된 담낭암 환자를 사상의학적 관리를 통해 제반 증상과 삶의 질을 개선시킨 1례", 사상체질의학회지, 19(2), pp.187~194 (2007), 사상체질의학회
- 송창훈, "원위부 담도암 환자 증례 보고", 대한한방내과학회지, 27(3), pp.771~776 (2006), 대한한방내과학회
- 서상훈, "췌장전이를 동반한 담도암환자 1례에 대한 보고", 대한한방내과학회지, 23(4), pp.735~740 (2002), 대한한방내과학회
- Mekeel KL, "Surgical management of gallbladder carcinoma: a review", J Gastrointest Surg, 11, pp.1188~1193 (2007)
- Chan CP, "A 10-year experience of unsuspected gallbladder cancer after laparoscopic cholecystectomy", Int Surg, 88, pp.175~179 (2003)
- Misra S, "Carcinoma of the gallbladder", Lancet Oncol, 4, pp.167~176 (2003)
- Muratore A, "Radical surgery for gallbladder cancer: a worthwhile operation?", Eur J Surg Oncol, 26, pp.160~163 (2000)
- Sean P. Cleary, "Cancer of the Gallbladder and Extrahepatic Bile Ducts", Current Problems in Surgery, 44(7), pp.396~482 (2007)
- Takada Tadahiro, "Is Postoperative Adjuvant Chemotherapy Useful for Gallbladder Carcinoma? : A Phase Ⅲ Multicenter Prospective Randomized Controlled Trial in Patients with Resected Pancreaticobiliary Carcinoma", Cancer, 95(8), pp.1685~1695 (2002)
- 이승원, "담낭암 환자에서 Gemcitabine을 기본으로 한 보조 항암화학요법의 경험", 대한외과학회지, 75(4), pp.255~261 (2008), 대한외과학회
- 이용연, "항암단을 투여한 대장암 환자 83례에 대한 임상보고", 대한한방종양학회지, 6(1), pp.165~180 (2000)
- 최병렬, "항암단을 투여한 유방암 환자 60례에 대한 임상보고", 대한한방내과학회지, 22(4), pp.669~674 (2001)
- 유승후, "항암단을 투여한 재발성 편평상피폐암 환자에 대한 7년간의 추적조사", 대한한방내과학회지, 28(2), pp.387~392 (2007), 대한한방내과학회
- 이남헌, "항암단으로 치료한 암환자 100례의 혈청 VFGF, bEGF 및 platelet 수치 변화", 대한한방내과학회지, 26(4), pp.753~760 (2005), 대한한방내과학회